연구동향 분석

원저 : 한국인 피부과환자에서 Methotrexate 치료효과 및 부작용

김영지 ( Young Jee Kim ) 윤숙정 ( Sook Jung Yun ) 이지범 ( Jee Bum Lee ) 김성진 ( Seong Jin Kim ) 원영호 ( Young Ho Won ) 이승철 ( Seung Chul Lee ) 2014년

논문상세정보
인용/피인용
' 원저 : 한국인 피부과환자에서 Methotrexate 치료효과 및 부작용' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • adverse effect
  • methotrexate
  • risk factor
  • therapeuticresponse
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
235 0

0.0%

' 원저 : 한국인 피부과환자에서 Methotrexate 치료효과 및 부작용' 의 참고문헌

  • Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks
    Naldi L Br J Dermatol 152 : 597 ~ 615 [2005]
  • The use of methotrexate in dermatology: a review
    Shen S Australas J Dermatol 53 : 1 ~ 18 [2012]
  • The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis
    Chladek J Eur J Clin Pharmacol 64 : 347 ~ 355 [2008]
  • The association between psoriasis and dyslipidaemia: a systematic review
    Ma C Br J Dermatol 168 : 486 ~ 495 [2013]
  • Short-term methotrexate therapy in psoriasis: a study of 197 patients
    Kumar B Int J Dermatol 41 : 444 ~ 448 [2002]
  • Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis
    Chalmers RJ Br J Dermatol 152 : 444 ~ 450 [2005]
  • Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies
    Armstrong AW J Am Acad Dermatol 68 : 654 ~ 662 [2013]
  • Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis
    Yeo CM World J Hepatol 5 : 275 ~ 280 [2013]
  • Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen
    Maurice PD Br J Dermatol 152 : 451 ~ 458 [2005]
  • Methotrexate versus Cyclosporine in Moderate-to-Severe Chronic Plaque Psoriasis
    Heydendael VMR New England Journal of Medicine 349 : 658 ~ 665 [2003]
  • Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity
    Montaudie H J Eur Acad Dermatol Venereol 25 Suppl 2 : 12 ~ 18 [2011]
  • Methotrexate in psoriasis: 26years' experience with low-dose long-term treatment
    Haustein UF J Eur Acad Dermatol Venereol 14 : 382 ~ 388 [2000]
  • Methotrexate in dermatology
    Bangert CA Dermatol Ther 20 : 216 ~ 228 [2007]
  • Methotrexate for psoriasis in the era of biological therapy
    Warren RB Clin Exp Dermatol 33 : 551 ~ 554 [2008]
  • Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference
    Kalb RE J Am Acad Dermatol 60 : 824 ~ 837 [2009]
  • Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors
    Miller IM J Am Acad Dermatol 69 : 1014 ~ 1024 [2013]
  • Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)
    Saurat JH Br J Dermatol 158 : 558 ~ 566 [2008]
  • Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)
    Barker J Br J Dermatol 165 : 1109 ~ 1117 [2011]
  • Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study
    Van Ede AE Arthritis Rheum 44 : 1515 ~ 1524 [2001]
  • Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial
    Braun J Arthritis Rheum 58 : 73 ~ 81 [2008]
  • Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002-2008
    Takahashi H J Dermatol 38 : 1125 ~ 1129 [2008]